Self-stigma and antiretroviral therapy adherence among people living with HIV/AIDS: A cross-sectional study
Journal of Community Nursing and Primary Care · 06.06.2026 · 3 (1) · 39-55
DOI: 10.63202/jcnpc.v3i1.178 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Community Nursing and Primary Care, online erschienen am 06.06.2026. Verfasst von Chinedu Okafor und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Health-seeking behavior remains a critical determinant of health outcomes in coastal Self-stigma remains a critical psychosocial challenge among people living with HIV/AIDS and may interfere with long-term engagement in antiretroviral therapy. Internalized shame, fear of disclosure, and negative self-perception can disrupt medication-taking routines and reduce adherence, particularly in settings where HIV-related stigma remains socially embedded.
Objective
This study aimed to examine the association between self-stigma and antiretroviral therapy adherence among people living with HIV/AIDS attending a Nigerian antiretroviral therapy clinic.
Methods
This analytical cross-sectional study was conducted among 87 adults receiving antiretroviral therapy at a single HIV clinic. Consecutive sampling was used to recruit eligible respondents during the data collection period. Self-stigma was measured using the Internalized AIDS-Related Stigma Scale, while adherence was assessed using the AIDS Clinical Trials Group Adherence Questionnaire. Data were analyzed using descriptive statistics, Fisher’s exact test, independent samples t-test, Spearman’s rank correlation, and multivariable logistic regression. Statistical significance was set at p < 0.05.
Results
Respondents with suboptimal adherence had significantly higher self-stigma scores than those with optimal adherence (18.8 ± 3.6 vs. 13.7 ± 4.0; p < 0.001). Self-stigma showed a moderate negative correlation with adherence percentage (r = -0.49; p < 0.001). Multivariable logistic regression showed that moderate self-stigma (AOR = 0.39; 95% CI: 0.13–0.92; p = 0.034) and high self-stigma (AOR = 0.16; 95% CI: 0.04–0.59; p = 0.006) were independently associated with lower odds of optimal adherence.
Conclusion
Self-stigma was significantly associated with poorer antiretroviral therapy adherence among people living with HIV/AIDS in this Nigerian ART clinic. The findings should be interpreted cautiously because of the cross-sectional design, single-clinic setting, and modest sample size. HIV care services should integrate stigma-sensitive adherence counseling, safe disclosure support, family-based support, and clinic retention strategies into routine treatment programs.
Zitieren
APA
Okafor, C., & Bello, A. (2026). Self-stigma and antiretroviral therapy adherence among people living with HIV/AIDS: A cross-sectional study. Journal of Community Nursing and Primary Care, 3(1), 39-55. https://doi.org/10.63202/jcnpc.v3i1.178
Vancouver
Okafor C, Bello A. Self-stigma and antiretroviral therapy adherence among people living with HIV/AIDS: A cross-sectional study. Journal of Community Nursing and Primary Care. 2026;3(1):39-55. doi:10.63202/jcnpc.v3i1.178
BibTeX
@article{Okafor2026,
author = {Okafor, Chinedu and Bello, Amina},
title = {Self-stigma and antiretroviral therapy adherence among people living with HIV/AIDS: A cross-sectional study},
journal = {Journal of Community Nursing and Primary Care},
year = {2026},
volume = {3},
number = {1},
pages = {39--55},
doi = {10.63202/jcnpc.v3i1.178}
}
EUVIMED